Literature DB >> 32448041

Covid-19 induced superimposed bacterial infection.

Mohamed A Hendaus1,2, Fatima A Jomha3.   

Abstract

Viral respiratory infections are very common and they are frequently eliminated from the body without any detrimental consequences. Secondary serious bacterial infection has been an apprehension expressed by health care providers, and this fear has been exacerbated in the era of Covid-19. Several published studies have shown an association between Covid-19 illness and secondary bacterial infection. However, the proposed mechanism by which a virus can develop a secondary bacterial infection is not well delineated. The aim of this commentary is to update the current evidence of the risk of bacterial infection in patients with Covid-19. We present several clinical studies related to the topic as well as a brief review of the potential pathophysiology of secondary infections that could present with Covid-19.Communicated by Ramaswamy H. Sarma.

Entities:  

Keywords:  Covid-19; pathogenesis; secondary bacterial infection; studies

Year:  2020        PMID: 32448041     DOI: 10.1080/07391102.2020.1772110

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  13 in total

Review 1.  Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure.

Authors:  Osama A Badary; Marwa S Hamza; Rajiv Tikamdas
Journal:  Drug Des Devel Ther       Date:  2021-05-03       Impact factor: 4.162

2.  A computational approach for the screening of potential antiviral compounds against SARS-CoV-2 protease: Ionic liquid vs herbal and natural compounds.

Authors:  Juhi Saraswat; Prashant Singh; Rajan Patel
Journal:  J Mol Liq       Date:  2021-01-07       Impact factor: 6.165

3.  Clinical Characteristics and Immune Responses of 137 Deceased Patients With COVID-19: A Retrospective Study.

Authors:  Ning Cui; Rongdi Yan; Chunyuan Qin; Jingming Zhao
Journal:  Front Cell Infect Microbiol       Date:  2020-12-07       Impact factor: 5.293

4.  Pleural complications in patients with coronavirus disease 2019 (COVID-19): how to safely apply and follow-up with a chest tube during the pandemic?

Authors:  Kenan Can Ceylan; Guntug Batihan; Serkan Yazgan; Soner Gürsoy; Sami Cenk Kıraklı; Sena Ataman
Journal:  Eur J Cardiothorac Surg       Date:  2020-12-01       Impact factor: 4.191

5.  COVID-19 and the second wave during autumn: preventive strategies in cardiac and thoracic surgery divisions.

Authors:  Francesco Donatelli; Antonio Miceli; Silvia Cirri; Enrico Coscioni; Claudio Napoli
Journal:  Eur Surg       Date:  2020-12-10       Impact factor: 0.953

Review 6.  How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms?

Authors:  Masoumeh Azimirad; Maryam Noori; Hamideh Raeisi; Abbas Yadegar; Shabnam Shahrokh; Hamid Asadzadeh Aghdaei; Enrico Bentivegna; Paolo Martelletti; Nicola Petrosillo; Mohammad Reza Zali
Journal:  Front Med (Lausanne)       Date:  2021-12-13

7.  Evaluation of Bi-Lateral Co-Infections and Antibiotic Resistance Rates among COVID-19 Patients.

Authors:  Naveed Ahmed; Madiha Khan; Waqas Saleem; Mohmed Isaqali Karobari; Roshan Noor Mohamed; Artak Heboyan; Ali A Rabaan; Abbas Al Mutair; Saad Alhumaid; Salman A Alsadiq; Ahmed S Bueid; Eman Y Santali; Jeehan H Alestad
Journal:  Antibiotics (Basel)       Date:  2022-02-19

8.  The impact of secondary infections in COVID-19 critically ill patients.

Authors:  Federica Murgia; Maura Fiamma; Silvia Serra; Sabrina Olla; Maria Cristina Garau; Eleonora Cocco; Lorena Lorefice; Sandro Muntoni; Peppino Paffi; Stefano Porru; Marta Abis; Gabriele Finco; Saverio Bellizzi; Orietta Massidda; Franco Carta; Luigi Atzori
Journal:  J Infect       Date:  2022-03-18       Impact factor: 38.637

9.  Pharmacotherapy for Hospitalized Patients with COVID-19: Treatment Patterns by Disease Severity.

Authors:  Kueiyu Joshua Lin; Sebastian Schneeweiss; Helen Tesfaye; Elvira D'Andrea; Jun Liu; Joyce Lii; Shawn N Murphy; Joshua J Gagne
Journal:  Drugs       Date:  2020-12       Impact factor: 11.431

Review 10.  Bacterial co-infections with SARS-CoV-2.

Authors:  Rasoul Mirzaei; Pedram Goodarzi; Muhammad Asadi; Ayda Soltani; Hussain Ali Abraham Aljanabi; Ali Salimi Jeda; Shirin Dashtbin; Saba Jalalifar; Rokhsareh Mohammadzadeh; Ali Teimoori; Kamran Tari; Mehdi Salari; Sima Ghiasvand; Sima Kazemi; Rasoul Yousefimashouf; Hossein Keyvani; Sajad Karampoor
Journal:  IUBMB Life       Date:  2020-08-08       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.